Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
3.070
+0.210 (7.34%)
At close: Nov 6, 2026, 4:00 PM EST
3.130
+0.060 (1.95%)
After-hours: Nov 6, 2026, 5:43 PM EST

CRBP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
59151144271477
Market Cap Growth
-71.51%4.94%437.89%93.01%-82.05%-26.60%
Enterprise Value
-5449-1221-27-4
Last Close Price
2.868.1411.806.043.3218.47

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----87.45
PB Ratio
0.521.021.01-3.870.421.12
P/TBV Ratio
0.581.021.01-0.421.12

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.010.02-3.020.760.39
Net Debt / Equity Ratio
-1.11-1.10-1.020.00-1.03-1.03
Net Debt / EBITDA Ratio
1.071.903.0301.001.29
Net Debt / FCF Ratio
1.312.513.490.000.911.47
Asset Turnover
-----0.01
Quick Ratio
5.567.9612.610.664.685.74
Current Ratio
5.718.0712.940.744.765.89
Return on Equity (ROE)
-95.58%-54.18%-59.34%-341.99%-82.95%-79.80%
Return on Assets (ROA)
-53.00%-32.91%-33.07%-59.57%-25.02%-33.32%
Return on Capital Employed (ROCE)
-101.30%-57.80%-33.80%1244.60%-64.90%-61.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-198.33%-52.07%-27.98%-166.94%-305.90%-59.19%
FCF Yield
-145.99%-42.76%-29.08%-135.11%-271.30%-62.56%
Buyback Yield / Dilution
-37.35%-22.00%-152.23%-3.76%-1.85%-57.23%
SEC Filings: 10-K · 10-Q